Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncor sells division to improve liquidity:

This article was originally published in Clinica

Executive Summary

Oncor has sold its research products division, which had sales to non-affiliates of around $3 million, to Intergen for $3.2 million. In addition the company, which is attempting to commercialise its INFORM HER-2/neu test for prediction of breast cancer recurrence, will receive cash infusions from its bank, following further credit guarantees from certain directors and a shareholder. The $4 million will be used to support the operations of the Gaithersburg, Maryland-based company at least until the end of the third quarter of this year and pay off some of its debt.

Topics

UsernamePublicRestriction

Register

MT081813

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel